The KARE Phase 2 trial was a randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of Oral KORSUVA for moderate-to-severe pruritus in 401 adult subjects with atopic dermatitis.

EOP2 Meeting target at 2H 2022.感觉凉了一半，如果三期选mild to moderate人群，也未必能做出优效来.$Cara Therapeutics(CARA)$